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ABSTRACT  
Mesothelial cells lining the peritoneal cavity are strategically positioned to respond to 
and counter intraperitoneal infections, cancer cells, and other challenges. We have 
investigated human peritoneal mesothelial cells (HPMCs) for phagocytic activity, expression 
of surface Major Histocompatibility Complex (MHC) Class II and accessory molecules 
involved in antigen presentation, and the ability to present recall antigens to T cells. 
Phagocytosis of dextran, latex beads and Escherichia coli was observed by flow cytometry, 
and internalization was visualised using confocal and electron microscopy. Flow cytometry 
and/or cellular ELISA showed constitutive expression of ICAM-I, LFA-3, and B7-1, but not 
B7-2 or MHC II. Interferon-gamma induced MHC II and ICAM-1 expression in a dose- and 
time-dependent manner. Importantly, HPMCs induced autologous CD3+ T lymphocyte 
proliferation (3H-incorporation) after pulse with recall antigen. HPMCs equipped with 
phagocytic and antigen-presenting machinery are anticipated to have an integral role in 
intraperitoneal immune surveillance.   
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INTRODUCTION 
The peritoneal cavity encounters and responds to damaging cell types, 
microorganisms, and foreign antigens, which include ovarian cancer metastases, intraperitonal 
infection, peritoneal dialysis, and endometriosis. It is lined with an epithelial monolayer, the 
mesothelium, formed by human peritoneal mesothelial cells (HPMCs) and contains resident 
and migratory immunological cells - macrophages, T cells, and natural killer (NK) cells.1 
Historically, it was thought innate immune cells provided the first line of defense, but 
evidence suggests HPMCs may have a significant immunological role.2  
Under certain conditions, non-immune cell types such as fibroblasts3 and endothelial 
cells4 display immune functions including release of pro-inflammatory cytokines and 
chemokines, phagocytosis of particles and microorganisms, and antigen presentation. Some 
recent reports indicate that HPMCs have antigen presenting capacity, phagocytic activity,5,6 
and can express Major Histocompatibility Complex (MHC) class II and intracellular adhesion 
molecule (ICAM).7,8 
Herein we report that HPMCs show the classical properties of accessory cells for T-
cell responses - phagocytic activity, induction of MHC II, and expression of accessory 
molecules ICAM-1, LFA-3, and B7-1. Functionally, HPMCs were capable of recall antigen-
induced autologous T cell activation, represented by T lymphocyte proliferation. 
 
MATERIALS AND METHODS 
All reagents are from Sigma Aldrich (Poole, UK) unless stated otherwise.  
Primary HPMCs (passage 2-4), derived from normal human omentum biopsies (study 
approved by local Research Ethics Committee) were maintained as described.9, 10 The 
following cells were used for comparison purposes: HMrSV5, immortalised human peritoneal 
mesothelium cells (gift from R Piedagnel9); mouse ovarian surface epithelial (mOSE) cells 
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(gift from BC Vanderhyden10), SKOV3 ovarian cancer cell line (European Collection of Cell 
Cultures, ECACC), THP-1 human monocytic leukaemia cell line (ECACC) pre-treated for 
24h with phorbol 12-myristate 13-acetate (PMA, 100ng/ml), and human umbilical vein 
endothelial cells (HUVECs, ECACC). Peripheral blood mononuclear cells (PBMCs) from 
healthy donors were isolated by Histopaque density gradient centrifugation. T lymphocytes 
were enriched magnetically (Pan T Cell Isolation Kit, Miltenyi Biotec, Surrey, UK).  
To measure phagocytic uptake activity, HPMCs in suspension were incubated in 
complete media (CM) containing: 1) FITC–dextran; 2) polystyrene red fluorescent latex 
beads (ø, 0.8µm); or 3) E. coli. Uptake was quantified using flow cytometry [FACScan, 
Becton Dickinson; data analysis: Cellquest™ (BDIS, San Jose, CA) and/or FlowJo software 
(Tree Star, Inc.)]. Expression of cell surface antigens was also detected by flow cytometry 
(Table 1).  
To visualise phagocytic uptake, HPMCs were cultured on coverslips to 70-80% 
confluence, then exposed to latex beads or green fluorescent E.coli for 8h. For confocal 
microscopy (Leica TCS/SP2), cells were fixed (4% paraformaldehyde, 1h), permeabilised 
with 0.5% Triton X-100, and counterstained with AlexaFluor546-phalloidin (F-actin), and 
To-PRO-3 (nuclei, Molecular Probes). For electron microscopy (EM, Phillips CM100BIO), 
cells were fixed in 2.5% gluteraldehyde in 0.1 M Sörensen’s Phosphate buffer (pH 7.4; 4oC 
overnight), post-fixed (2h, room temperature) in 1% osmium tetroxide, dehydrated, and resin-
embedded. Transverse sections of monolayers were stained with uranyl acetate and lead 
citrate prior to visualisation. 
For Cellular Enzyme-Linked Immunosorbent Assay (C-ELISA), HPMCs cultured 
with various stimuli were fixed (0.5% periodate-lysine-parafomaldehyde), permeabilised 
(0.1% saponin), and then incubated with primary antibodies (1h). The Vectastain Universal 
Elite ABC kit (Vector Laboratories) was used for visualization (OD490nm). Subsequent 
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staining with 0.08% crystal violet, and measurement of OD550nm determined total cells/well. 
Western blotting was conducted according to standard protocol (Merck Millipore), using 
precast polyacrylamide 8-16% gradient tris-glycine gels (Generon, UK) that were transferred 
to nitrocellulose membrane. Blots were blocked in 5% milk and blotted for ICAM-1 (Santa 
Cruz Biotechnology, Inc., USA) or glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 
Abcam, UK). Horseradish peroxidase-conjugated secondary antibodies were used, and results 
were visualised using a Bio-Rad ChemiDoc MP system.  
To measure accessory cell-dependent antigen-induced T cell proliferation, CD3+ T 
cells in RPMI1640 with 10% human AB serum (105/well) were added to 96-well round-
bottomed plates. Autologous HPMCs were irradiated (50Gy), washed, and added to the above 
plates in a dilution series (1×104 to 1.25×103/well). Tuberculin purified protein derivatives 
(PPD, 500 IU/ml) were applied to all test wells (or omitted for the control), and cells cultured 
for 6d. Cells were labelled for the final 16h with 1.0 µCi/well [3H]thymidine (ICN 
Biomedicals, Inc.), harvested onto glass fibre filter mats, and the incorporated radioactivity 
measured (Wallac 1450 microbeta liquid scintillation counter).  
 
RESULTS 
Incorporation of FITC-dextran, latex beads, and E. coli by HPMC   
To investigate phagocytic capabilities, HPMC were incubated with fluorescently-
tagged dextran particles or polystyrene latex beads (Fig. 1A). Flow cytometry revealed strong 
fluorescent signal in ~80% of cells incubated with FITC-dextran for 30min, and in ~50% of 
cells incubated with latex beads, whereas there was minimal uptake in cells incubated on ice. 
Time-course analysis of incorporation of latex beads showed that mean fluorescent intensity 
(MFI) fluctuated at baseline levels for 2h, then significantly increased, at which time the 
percentage of cells having engulfed beads also increased, again peaking near 50% at the 
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conclusion of the 24h experiment (Fig. 1B). This heterogeneity in phagocytic capabilities was 
observed to a comparable extent in the HMrSV5 mesothelial cell line, as well as THP-1 and 
HUVEC cells (Fig. 1C). Mouse ovarian surface epithelial cells and the SKOV3 ovarian 
cancer cell line however, were much more uniformly capable of engulfment (~90%, Fig 1C). 
Confocal and EM were used to verify that HPMCs had internalised the particles (Fig. 1D, 
EM; Fig. 1E, confocal microscopy).  
To further understand the phagocytic mechanisms of HPMCs, cells were first analysed 
by flow cytometry for the expression of human immunoglobulin Fcγ receptors. None of our 
HPMC cells expressed detectable levels of CD16 (FcRIII), CD32 (FcRII), or CD64 
(FcRI)(data not shown), and when E. coli were pre-opsonised with 10% pooled human serum 
the rate of phagocytosis was unchanged (data not shown). Also, cells were negative for 
mannose receptor (a C-type lectin that also mediates pre-phagocytosis binding;11 data not 
shown), suggesting alternative machinery is responsible for the uptake.  
To investigate the ability of HPMCs to provide antigen specific signals for the 
activation of naïve T cells we studied the membrane expression of MHC molecules by FC and 
C-ELISA. High levels of cell surface MHC I (HLA-A,B,C) were demonstrated in resting 
HPMCs, whereas MHC II (HLA-DP,DR,DQ) expression was not detected in the basal state 
(Fig. 2A). However, HLA-DP,DR,DQ was induced by pre-treatment with 100 U/ml of IFN-γ 
for 72h, but not by TNF-α, IL-1β or LPS (Fig. 2B). A time-course experiment showed MHC 
II induction as early as 24h, and persistence of expression beyond 96h, even after withdrawal 
of IFN-γ (data not shown).  
The ability of HPMCs to activate T cells was explored first by examining their 
constitutive expression of co-stimulatory molecules by flow cytometry. High levels of ICAM-
1, and intermediate levels of LFA-3 and B7-1 were expressed, but the expression of B7-2 was 
negligible (Fig. 2C). Modulation of their expression by cytokines (IFN-γ, TNFα, IL1β, or 
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LPS) was assessed by C-ELISA, showing that only ICAM-1 expression (not LFA-3 or B7-
1/2) was modulated by treatments, and only IFN-γ could induce its expression. The IFN-γ-
inducible increase in ICAM-1 expression was significant at 4h, near maximum at 24h, 
persisted for at least 72h (Fig. 2D) and was concentration-dependent (Fig. 2E). Western 
blotting indicated that ICAM-1 induction by IFN-γ occurred to a comparable extent in other 
similar cell lineages, HUVECs and SKOV3, when considered alongside HMrSV5 (Fig. 2F). 
The potential of normal HPMCs to present antigen was evaluated with an autologous 
T cell proliferation assay. HPMCs were co-cultured with autologous CD3+ T lymphocytes 
purified from the peripheral blood of PPD immunized individuals. These cells induced HPMC 
proliferation ([3H]thymidine-incorporation) in response to recall antigen (PPD) in a cell ratio-
dependent manner, which at the highest HPMC:T cell ratio of 1:10 was significantly 
enhanced relative to the control without PPD (Fig. 2G).  
 
DISCUSSION 
Intraperitoneal cancer, surgery, and infection can breach the sterile homeostatic 
environment of the peritoneal cavity; accordingly, there are a number of defense mechanisms. 
In addition to the immune cells in the peritoneal fluid, the peritoneal monolayer (HPMCs) 
also provide a line of defense: it is a semi-permeable physical barrier, with anti-inflammatory 
activity.12 Intuitively, HPMCs should have an immunological role, and we and others have 
shown that they can produce many immunomodulatory cytokines and growth factors.13 Our 
data now add to other evidence that HPMCs are phagocytic and have many of the features of 
a non-professional antigen-presenting cell (APC).  
The phagocytic activity of HPMCs substantiate other reports that HPMCs can engulf 
microorganisms and apoptotic cancer cells.5,6,14 That only ~50% of cells engulfed particles, a 
level seemingly on par with other cell lineages including monocyte-derived cells and 
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endothelial cells, interestingly suggests HPMCs may be a functionally heterogeneous 
population, with a range of maturation or activation states. 
Phagocytosis is a receptor-mediated process initiated when a foreign particle binds to 
an opsonin receptor such as Fcγ or CR3.11 Alternatively, there are opsonin-independent 
mechanisms including C-type lectin mediated binding.11 As reported by others,6,14 
Fcγ receptor expression was undetectable on HMPC cultures, and correspondingly, 
opsonisation did not enhance particle uptake. Mannose receptor expression was also 
undetectable; however, other non-opsonin receptors (e.g. Stab2, Axl, Tyro3) were identified 
to be expressed by HPMCs by Wagner et al.6 These alternative strategies used by non-
professional phagocytes are effective, but likely less efficient with a narrower target particle 
range.15 
The quantitative level of surface MHC expression is a determinant of antigen-
presenting capacity; as expected, we found resting HPMCs constitutively expressed MHC I 
molecules, but there was no detectable MHC II. However, this could be induced by IFN-γ in a 
time- and concentration-dependent manner, as reported by Hausmann et al.7 In contrast, Valle 
et al reported that some primary cultures do express resting levels,8 which may reflect the 
health status of the donor.  
A second signal critical for T-cell activation is typically derived from co-stimulatory 
molecules [e.g. ICAM-1 (CD54), LFA-3 (CD58), and B7-1 (CD80)].16 We show that HPMCs 
constitutively expressed intermediate levels of surface ICAM-1 and LFA-3, and low levels of 
B7-1. Moreover, ICAM-1 expression was up-regulated by IFN-γ stimulation in a time- and 
concentration-dependent manner, with minimal influence by TNF-α or IL-1β. This IFN-γ 
induced enhancement of ICAM-1 has similarly been observed by others in mesothelium,7,8 
and was shown here to be a feature shared by endothelial and SKOV3 ovarian cancer cells. 
Mesothelial LFA-3 and B7-1 expression has not been previously recognised however.  
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With the essential molecular prerequisites on HPMCs, we next demonstrated their 
functionality: HPMCs efficiently processed and presented recall antigen to autologous T cells. 
Interestingly, this occurred in the absence of additional IFN-γ, and was not augmented by 
further IFN-γ. One possible explanation is that unstimulated HPMCs expressed low levels of 
MHC II, undetected here but sufficient to induce antigen-specific proliferative T cell 
responses. Alternatively, the HPMCs and/or T-cells may have produced IFN-γ or an 
alternative signal in the co-culture, which in turn induced maximal MHC II and ICAM-1 
expression.  
In conclusion, normal HPMCs have a significant inherent phagocytic activity, can be 
induced to produce MHC II, and constitutively express co-stimulatory molecules. Moreover, 
they can present recall antigen to autologous memory T lymphocytes. Characterization of the 
role(s) of these amateur phagocytes in local host defense mechanisms will improve our 
understanding of the consequences of damage to this tissue lining and may lead to new 
therapies for intraperitoneal diseases. 
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Figure legends 
Fig. 1 Human peritoneal mesothelial cells (HPMCs) phagocytose dextran, latex beads 
and E. coli. (A) Primary HPMCs, in suspension, were incubated on ice (4oC, blue) or at 37°C 
(red) with FITC-dextran (Sigma, MW 43,200 Da, 1mg/ml) for 30min, or red fluorescent 
polystyrene latex beads (ø, 0.88µm, 10:1 particle:cell) for 24h. The uptake was detected by 
flow cytometry (5000 cells analysed). (B) Percentage of cells containing beads (left y axis, 
black) and mean fluorescent intensity (MFI) per cell (representing internalised beads, right y 
axis, blue) are plotted against incubation time (n≥3, representative experiment shown). (C) 
For comparison, HMrSV5, THP-1, HUVEC, mOSE and SKOV3 were also incubated in 
suspension with FITC-dextran on ice (blue) or at 37°C (red) for 2h, and analysed by flow 
cytometry. (D) HPMCs incubated with latex beads for 8h at 37oC were processed for electron 
microscopy (scale bar 5µm). (E) HPMCs incubated with E. coli (K-12 strain, AlexaFluor488-
conjugated, Molecular Probes; 10:1 particle:cell) for 8h were fixed in 4% paraformaldehyde, 
and stained with AlexaFluor546 phalloidin (red) and To-PRO-3 (nuclear stain, blue). Medial 
transverse (G, top) and medial sagittal sections (G, bottom) are shown (scale bar 10µm).  
Fig. 2. HPMCs express MHC Class I and II molecules, co-stimulatory molecules and 
have antigen-presenting capacity. (A, C) Representative flow cytometric results of resting 
HPMCs. (A) Surface membrane HLA-A,B,C were detected, but not HLA-DP,DR,DQ. (C) 
Surface membrane ICAM-1 (CD54), LFA3 (CD58), and B7-1 (CD80) were detected, but not 
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B7-2 (CD86). Red lines show isotype controls, black lines represent specific antibody 
staining (n≥3, representative experiment shown). (B, D, E) Representative C-ELISA results 
of (B) HLA-DP,DR,DQ or (D, E) ICAM-1 expression in response to: IFN-γ (100 U/ml) or 
TNF-α (100 U/ml) or IL-1β (10 ng/ml) or LPS (1µg/ml; E. coli serotype 0127:B8; Sigma), or 
(E) IFN-γ (0-1000 U/ml) for 72h. Graphs represents mean±SD of duplicate measurements 
from three experiments with two HPMC lines. Data are expressed as ratios of OD490 to 
OD550 to normalise for cells/well. (F) SKOV3, HMrSV5 and HUVEC cells cultured ± IFN-γ 
(100 U/ml) for 24h were analysed by western blot for ICAM-1 and GAPDH (loading control). 
(G) Irradiated (50Gy) HPMCs (1×104 to 1.25×103/well in 96-well plates) were co-incubated 
with autologous CD3+ T lymphocytes (105/well) at a HPMC:T cell ratio ranging from 1:80 to 
1:10 ± recall antigen (tuberculin purified protein derivate, PPD, 500 IU/ml). Control ratio (no 
PPD) was 1:10. Proliferation was measured by [3H]thymidine uptake (1.0 µCi/well) over final 
16h of a 6d co-culture; data are presented as the average counts per minute (cpm) of the 
triplicate wells of a representative experiment (conducted in duplicate with cells from four 
donors). Significance was assessed by ANOVA with Tukey’s multiple comparison test 
(significance inferred at p<0.05, *, GraphPad Prism).  
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Table 1. Antibodies used for analyses. 
Antigen Unconjugated, Supplier Conjugate, Supplier 
ICAM-1 (CD54) BD Bioscience FITC, Serotec 
LFA-3 (CD58) BD Bioscience FITC, Serotec 
HLA-ABC BD Bioscience FITC, Serotec 
HLA-DP,DQ,DR BD Bioscience FITC, Serotec 
CD64 (Clone 10.1) n/a FITC, BD Bioscience 
CD206 (mannose 
receptor)(Clone 19.2) 
n/a FITC, BD Bioscience 
B7-1 (CD80) BD Bioscience PE, Serotec 
B7-2 (CD86) n/a PE, Serotec 
CD14 (Clone TUK4) n/a PE, DAKO 
CD16 (Clone DJ130c) n/a PE, DAKO 
CD3 n/a PerCP, BD Bioscience 
CD32 (Clone 3D3) BD Bioscience n/a 	  	  	  	  
